The physical microenvironment of hematopoietic stem cells and its emerging roles in engineering applications

P Zhang, C Zhang, J Li, J Han, X Liu… - Stem Cell Research & …, 2019 - Springer
Stem cells are considered the fundamental underpinnings of tissue biology. The stem cell
microenvironment provides factors and elements that play significant roles in controlling the …

CRISPR–Cas9-mediated gene editing of the BCL11A enhancer for pediatric β00 transfusion-dependent β-thalassemia

B Fu, J Liao, S Chen, W Li, Q Wang, J Hu, F Yang… - Nature medicine, 2022 - nature.com
Gene editing to disrupt the GATA1-binding site at the+ 58 BCL11A erythroid enhancer could
induce γ-globin expression, which is a promising therapeutic strategy to alleviate β …

Mass cytometry for the assessment of immune reconstitution after hematopoietic stem cell transplantation

L Stern, H McGuire, S Avdic, S Rizzetto… - Frontiers in …, 2018 - frontiersin.org
Mass cytometry, or Cytometry by Time-Of-Flight, is a powerful new platform for high-
dimensional single-cell analysis of the immune system. It enables the simultaneous …

Current approaches in biomaterial-based hematopoietic stem cell niches

AB Bello, H Park, SH Lee - Acta biomaterialia, 2018 - Elsevier
Hematopoietic stem cells (HSCs) are multipotent progenitor cells that can differentiate and
replenish blood and immune cells. While there is a growing demand for autologous and …

Evolution of nutritional status in patients with autologous and allogeneic hematopoietic stem cell transplant

RLB de Defranchi, A Bordalejo, I Cañueto… - Supportive Care in …, 2015 - Springer
Purpose To describe the nutritional status in patients undergoing hematopoietic stem cell
transplant (HSCT) in three different defined moments: at admission to the Bone Marrow …

A concise review on factors influencing the hematopoietic stem cell transplantation main outcomes

M Rafiee, M Abbasi, H Rafieemehr… - Health Science …, 2021 - Wiley Online Library
Background and aims As a curative procedure, hematopoietic stemcell transplantation
(HSCT) is an approved treatment for many malignant orbenign hematologic and non …

High-dose chemotherapy and autologous stem cell transplantation in multiple myeloma: a single institution experience at All India Institute of Medical Sciences, New …

S Kayal, A Sharma, S Iqbal, T Tejomurtula… - … Myeloma and Leukemia, 2014 - Elsevier
Background Intravenous high-dose melphalan has a short half-life, and application of this
single drug in MM transplant favors the use of stem cells without cryopreservation, for wider …

Endothelial cells promote expansion of long-term engrafting marrow hematopoietic stem and progenitor cells in primates

JL Gori, JM Butler, B Kunar, MG Poulos… - Stem cells …, 2017 - academic.oup.com
Successful expansion of bone marrow (BM) hematopoietic stem and progenitor cells
(HSPCs) would benefit many HSPC transplantation and gene therapy/editing applications …

Decreased circulating myeloid-derived suppressor cell count at the engraftment is one of the risk factors for multiple myeloma relapse after autologous hematopoietic …

T Tyrinova, E Batorov, T Aristova, G Ushakova… - Heliyon, 2024 - cell.com
Recent studies demonstrated that myeloid-derived suppressor cells (MDSCs) are involved
in the pathogenesis and progression of multiple myeloma (MM). Nevertheless, data on the …

[HTML][HTML] Autologous peripheral blood stem cell transplantation among lymphoproliferative disease patients: factors influencing engraftment

MN Hassan, HM Fauzi, A Husin, R Mustaffa… - Oman medical …, 2019 - ncbi.nlm.nih.gov
Objectives Autologous peripheral blood stem cells transplantation (APBSCT) is a
therapeutic option which can be used in various hematological, neoplastic disorders …